Primary Site >> Pancreatic Cancer

Gene >> PTPRF

Journal: Yale J Biol Med. 1997 Sep-Dec;70(5-6):549-54.
Title: Indirect antiproliferative effect of the somatostatin analog octreotide on MIA PaCa-2 human pancreatic carcinoma in nude mice.
Author: Weckbecker, G|Raulf, F|Bodmer, D|Bruns, C
PMID: 9825482
Journal: J Clin Gastroenterol. 2001 Jan;32(1):54-8.
Title: Endosonography is superior to angiography in the preoperative assessment of vascular involvement among patients with pancreatic carcinoma.
Author: Ahmad, N A|Kochman, M L|Lewis, J D|Kadish, S|Morris, J B|Rosato, E F|Ginsberg, G G
PMID: 11154172
Journal: Gastroenterol Clin Biol. 2002 Oct;26(10):926-9.
Title: [Clinical response of an atypical glucagonoma treated with a long-acting somatostatin analog].
Author: Bouin, Mickael|Aoust, Louise D'
PMID: 12434103
Journal: J BUON. 2005 Jul-Sep;10(3):357-64.
Title: Phase II study of gemcitabine plus 5-fluorouracil biologically modulated by folinic acid plus long-acting formulation of octreotide (LAR) in patients with advanced pancreatic cancer.
Author: Polyzos, A|Tsavaris, N|Vafiadis, I|Polyzos, K|Griniatsos, J|Felekouras, E|Nikiteas, N I|Halikias, S|Nikou, G
PMID: 17357189
Journal: Horm Res. 2006;65(3):120-5.
Title: Complete clinical remission and disappearance of liver metastases after treatment with somatostatin analogue in a 40-year-old woman with a malignant insulinoma positive for somatostatin receptors type 2.
Author: Romeo, Stefano|Milione, Massimo|Gatti, Alessandra|Fallarino, Mara|Corleto, Vito|Morano, Susanna|Baroni, Marco Giorgio
PMID: 16479142
Journal: Endocr J. 2007 Feb;54(1):95-101. Epub 2006 Nov 24.
Title: Medical treatment of benign insulinoma using octreotide LAR: a case report.
Author: Usukura, Mikiya|Yoneda, Takashi|Oda, Nobushige|Yamamoto, Yasuhiro|Takata, Hiroyuki|Hasatani, Kenkou|Takeda, Yoshiyu
PMID: 17124362
Journal: JOP. 2011 Jul 8;12(4):425-8.
Title: Rheumatoid arthritis associated with the use of Sandostatin(R) LAR(R) depot in a patient with pancreatic neuroendocrine tumor. An association or a coincidence? The first case report.
Author: Saif, Muhammad Wasif
PMID: 21737909
Journal: Surgery. 2012 Dec;152(6):1068-77.
Title: Pasireotide (SOM230) is effective for the treatment of pancreatic neuroendocrine tumors (PNETs) in a multiple endocrine neoplasia type 1 (MEN1) conditional knockout mouse model.
Author: Quinn, Thomas J|Yuan, Ziqiang|Adem, Asha|Geha, Rula|Vrikshajanani, Chakravarthy|Koba, Wade|Fine, Eugene|Hughes, David T|Schmid, Herbert A|Libutti, Steven K
PMID: 23102680
Journal: JOP. 2014 Jul 28;15(4):322-5.
Title: Elderly patients with pancreatic cancer.
Author: Kougioumtzopoulou, Andromachi S|Syrigos, Kostas N|Saif, Muhammad Wasif
PMID: 25076333
Journal: Tumori. 2014 Nov-Dec;100(6):e286-9.
Title: Rationale and protocol of the MetNET-1 trial, a prospective, single center, phase II study to evaluate the activity and safety of everolimus in combination with octreotide LAR and metformin in patients with advanced pancreatic neuroendocrine tumors.
Author: Pusceddu, Sara|de Braud, Filippo|Concas, Laura|Bregant, Cristina|Leuzzi, Livia|Formisano, Barbara|Buzzoni, Roberto
PMID: 25688512
Journal: J Hepatobiliary Pancreat Sci. 2015 Aug;22(8):618-22.
Title: Biotherapy of pancreatic neuroendocrine tumors using somatostatin analogs.
Author: Igarashi, Hisato|Hijioka, Masayuki|Lee, Lingaku|Ito, Tetsuhide
PMID: 25689143
Journal: Cancer Chemother Pharmacol. 2015 Sep;76(3):481-7.
Title: Phase I study of combination of pasireotide LAR + gemcitabine in locally advanced or metastatic pancreatic cancer.
Author: Suleiman, Yaman|Mahipal, Amit|Shibata, David|Siegel, Erin M|Jump, Helen|Fulp, William J|Springett, Gregory M|Kim, Richard
PMID: 26126727
Journal: Gan To Kagaku Ryoho. 2016 Jan;43(1):107-10.
Title: [Treatment Strategy for Non-Functional Pancreatic Neuroendocrine Tumors (P-NETs) at Kurume University Hospital].
Author: Kawashima, Yusuke|Ishikawa, Hiroto|Hisaka, Toru|Okuda, Kouji|Akagi, Yoshito
PMID: 26809536
Journal: Jpn J Clin Oncol. 2018 May 1;48(5):434-441.
Title: 18F-fluorodeoxyglucose positron emission tomography to indicate conversion surgery in patients with initially unresectable locally advanced pancreatic cancer.
Author: Okano, Keiichi|Suto, Hironobu|Oshima, Minoru|Ando, Yasuhisa|Nagao, Mina|Kamada, Hideki|Kobara, Hideki|Masaki, Tsutomu|Okuyama, Hiroyuki|Okita, Yoshihiro|Tsuji, Akihito|Suzuki, Yasuyuki
PMID: 29590448
Journal: Future Oncol. 2018 Jun;14(14):1377-1386.
Title: Lactic dehydrogenase to albumin ratio in prediction of unresectable pancreatic cancer with intervention chemotherapy.
Author: Gao, Shanshan|Wu, Mengfei|Chen, Yi|Lou, Wenhui|Zhou, Guofeng|Li, Junhao|Yu, Tianzhu|Zhou, Yang|Liu, Lingxiao|Wang, Xiaolin
PMID: 29848124
Journal: Int J Endocrinol. 2018 Jul 2;2018:8126087.
Title: Chromogranin A: From Laboratory to Clinical Aspects of Patients with Neuroendocrine Tumors.
Author: Di Giacinto, Paola|Rota, Francesca|Rizza, Laura|Campana, Davide|Isidori, Andrea|Lania, Andrea|Lenzi, Andrea|Zuppi, Paolo|Baldelli, Roberto
PMID: 30057604